Anti-VEGF (Developments in Ophthalmology) - gebunden oder broschiert

2010, ISBN: 3805595298

[SR: 3661679], Hardcover, [EAN: 9783805595292], S Karger AG, S Karger AG, Book, [PU: S Karger AG], 2010-08-01, S Karger AG, The development of therapy with anti-angiogenics or vascular en.. Mehr…

[SR: 3661679], Hardcover, [EAN: 9783805595292], S Karger AG, S Karger AG, Book, [PU: S Karger AG], 2010-08-01, S Karger AG, The development of therapy with anti-angiogenics or vascular endothelial growth factor inhibitors (anti-VEGF) has marked the beginning of a new era in neovascularization and macular edema treatment. Its main goals are the inhibition of growth and development of new vessels along with the reduction of vascular permeability. The advantages over conventional laser photocoagulation are evident as laser treatment always leaves scars and causes a retinal sensitivity deterioration. Starting with an outline of treatment principles, this volume covers all aspects of anti-VEGF therapy for ophthalmological disorders. In particular, specific chapters are dedicated to age-related macular degeneration, degenerative myopia, angioid streaks, inflammatory diseases, hereditary dystrophies, retinal vein occlusion, diabetic retinopathy, ocular tumors, as well as anterior segment neovascularization. The book gives an update on the application of anti-VEGF in ocular diseases to general ophthalmologists as well as retina specialists., 270784, Optometry - Opticians, 270768, Ancillary Services, 270767, Medical & Healthcare Practitioners, 74, Health, Family & Lifestyle, 1025612, Subjects, 266239, Books, 270882, Ophthalmology, 270842, Internal Medicine, 270767, Medical & Healthcare Practitioners, 74, Health, Family & Lifestyle, 1025612, Subjects, 266239, Books, 922676, Ophthalmology, 922572, Medical Sciences A-Z, 922532, Medicine, 57, Science & Nature, 1025612, Subjects, 266239, Books, 571382, Medical Sciences A-Z, 571384, Anaesthetics, 571400, Cardiovascular, 571334, Diseases & Disorders, 571390, Gynaecology & Obstetrics, 571386, Neurology, 571316, Orthopaedic & Fractures, 571388, Paediatrics, 571362, Pathology, 571392, Psychiatry, 571290, Public Health & Preventive Medicine, 571350, Radiology & Medical Imaging, 571280, Research & Equipment, 571310, Surgery, 564356, Medicine & Nursing, 564334, Scientific, Technical & Medical, 1025612, Subjects, 266239, Books<

Gebraucht. Versandkosten:Europa Zone 1: GBP 5,48 pro Produkt.. Usually dispatched within 6-10 business days. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 4.80)

ISBN: 3805595298

[SR: 9137313], Hardcover, [EAN: 9783805595292], S. Karger, S. Karger, Book, [PU: S. Karger], S. Karger, The development of therapy with anti-angiogenics or vascular endothelial growth fac.. Mehr…

[SR: 9137313], Hardcover, [EAN: 9783805595292], S. Karger, S. Karger, Book, [PU: S. Karger], S. Karger, The development of therapy with anti-angiogenics or vascular endothelial growth factor inhibitors (anti-VEGF) has marked the beginning of a new era in neovascularization and macular edema treatment. Its main goals are the inhibition of growth and development of new vessels along with the reduction of vascular permeability. The advantages over conventional laser photocoagulation are evident as laser treatment always leaves scars and causes a retinal sensitivity deterioration. Starting with an outline of treatment principles, this volume covers all aspects of anti-VEGF therapy for ophthalmological disorders. In particular, specific chapters are dedicated to age-related macular degeneration, degenerative myopia, angioid streaks, inflammatory diseases, hereditary dystrophies, retinal vein occlusion, diabetic retinopathy, ocular tumors, as well as anterior segment neovascularization. The book gives an update on the application of anti-VEGF in ocular diseases to general ophthalmologists as well as retina specialists., 227196, Ophthalmology, 227199, Surgery, 265542, Medicine, 173514, Medical Books, 1000, Subjects, 283155, Books, 689754011, Ophthalmology, 689725011, Clinical, 689674011, Medicine, 468228, Medicine & Health Sciences, 465600, New, Used & Rental Textbooks, 2349030011, Specialty Boutique, 283155, Books<

Gebraucht. Versandkosten:Usually ships in 1-2 business days., zzgl. Versandkosten

ISBN: 3805595298

[SR: 9090022], Hardcover, [EAN: 9783805595292], S. Karger, S. Karger, Book, [PU: S. Karger], S. Karger, The development of therapy with anti-angiogenics or vascular endothelial growth fac.. Mehr…

[SR: 9090022], Hardcover, [EAN: 9783805595292], S. Karger, S. Karger, Book, [PU: S. Karger], S. Karger, The development of therapy with anti-angiogenics or vascular endothelial growth factor inhibitors (anti-VEGF) has marked the beginning of a new era in neovascularization and macular edema treatment. Its main goals are the inhibition of growth and development of new vessels along with the reduction of vascular permeability. The advantages over conventional laser photocoagulation are evident as laser treatment always leaves scars and causes a retinal sensitivity deterioration. Starting with an outline of treatment principles, this volume covers all aspects of anti-VEGF therapy for ophthalmological disorders. In particular, specific chapters are dedicated to age-related macular degeneration, degenerative myopia, angioid streaks, inflammatory diseases, hereditary dystrophies, retinal vein occlusion, diabetic retinopathy, ocular tumors, as well as anterior segment neovascularization. The book gives an update on the application of anti-VEGF in ocular diseases to general ophthalmologists as well as retina specialists., 227196, Ophthalmology, 227199, Surgery, 265542, Medicine, 173514, Medical Books, 1000, Subjects, 283155, Books, 689754011, Ophthalmology, 689725011, Clinical, 689674011, Medicine, 468228, Medicine & Health Sciences, 465600, New, Used & Rental Textbooks, 2349030011, Specialty Boutique, 283155, Books<

Gebraucht. Versandkosten:Usually ships in 1-2 business days., zzgl. Versandkosten

ISBN: 3805595298

[SR: 9137313], Hardcover, [EAN: 9783805595292], S. Karger, S. Karger, Book, [PU: S. Karger], S. Karger, The development of therapy with anti-angiogenics or vascular endothelial growth fac.. Mehr…

[SR: 9137313], Hardcover, [EAN: 9783805595292], S. Karger, S. Karger, Book, [PU: S. Karger], S. Karger, The development of therapy with anti-angiogenics or vascular endothelial growth factor inhibitors (anti-VEGF) has marked the beginning of a new era in neovascularization and macular edema treatment. Its main goals are the inhibition of growth and development of new vessels along with the reduction of vascular permeability. The advantages over conventional laser photocoagulation are evident as laser treatment always leaves scars and causes a retinal sensitivity deterioration. Starting with an outline of treatment principles, this volume covers all aspects of anti-VEGF therapy for ophthalmological disorders. In particular, specific chapters are dedicated to age-related macular degeneration, degenerative myopia, angioid streaks, inflammatory diseases, hereditary dystrophies, retinal vein occlusion, diabetic retinopathy, ocular tumors, as well as anterior segment neovascularization. The book gives an update on the application of anti-VEGF in ocular diseases to general ophthalmologists as well as retina specialists., 227196, Ophthalmology, 227199, Surgery, 265542, Medicine, 173514, Medical Books, 1000, Subjects, 283155, Books, 689754011, Ophthalmology, 689725011, Clinical, 689674011, Medicine, 468228, Medicine & Health Sciences, 465600, New, Used & Rental Textbooks, 2349030011, Specialty Boutique, 283155, Books<

Neuware. Versandkosten:Usually ships in 24 hours., zzgl. Versandkosten

ISBN: 3805595298

[SR: 9090022], Hardcover, [EAN: 9783805595292], S. Karger, S. Karger, Book, [PU: S. Karger], S. Karger, The development of therapy with anti-angiogenics or vascular endothelial growth fac.. Mehr…

[SR: 9090022], Hardcover, [EAN: 9783805595292], S. Karger, S. Karger, Book, [PU: S. Karger], S. Karger, The development of therapy with anti-angiogenics or vascular endothelial growth factor inhibitors (anti-VEGF) has marked the beginning of a new era in neovascularization and macular edema treatment. Its main goals are the inhibition of growth and development of new vessels along with the reduction of vascular permeability. The advantages over conventional laser photocoagulation are evident as laser treatment always leaves scars and causes a retinal sensitivity deterioration. Starting with an outline of treatment principles, this volume covers all aspects of anti-VEGF therapy for ophthalmological disorders. In particular, specific chapters are dedicated to age-related macular degeneration, degenerative myopia, angioid streaks, inflammatory diseases, hereditary dystrophies, retinal vein occlusion, diabetic retinopathy, ocular tumors, as well as anterior segment neovascularization. The book gives an update on the application of anti-VEGF in ocular diseases to general ophthalmologists as well as retina specialists., 227196, Ophthalmology, 227199, Surgery, 265542, Medicine, 173514, Medical Books, 1000, Subjects, 283155, Books, 689754011, Ophthalmology, 689725011, Clinical, 689674011, Medicine, 468228, Medicine & Health Sciences, 465600, New, Used & Rental Textbooks, 2349030011, Specialty Boutique, 283155, Books<

Neuware. Versandkosten:Usually ships in 24 hours., zzgl. Versandkosten